Clinical Trial Update: The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects [Phase 3]

View source ↗

Summary

A Phase III study comparing Icaritin to Huachansu Pian in advanced HBV-related hepatocellular carcinoma is in Phase 3 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Huachansu Pian (huachansu pian)
• Icaritin (icaritin)

Snippet

Sponsor: Beijing Shenogen Biomedical Co., Ltd | Conditions: Advanced HBV-Related Hepatocellular Carcinoma (HCC) | Phase 3 | Status: UNKNOWN